BRIEF published on 09/05/2024 at 09:05, 1 year 8 months ago Biotest AG ouvre son 13e centre de collecte de plasma en Allemagne Allemagne Biotest AG Collecte De Plasma Traitements Médicaux Défense Des Droits Des Patients
PRESS RELEASE published on 09/05/2024 at 09:00, 1 year 8 months ago Biotest AG opens 13th plasma collection center in Germany Biotest AG opens 13th plasma collection center in Germany to ensure long-term plasma supply. State-of-the-art center in Karlsruhe operated by Plasma Service Europe GmbH, a subsidiary of Biotest AG Donations Germany Biotest AG Plasma Collection Center Plasma Service Europe GmbH
BRIEF published on 08/28/2024 at 09:05, 1 year 8 months ago Dr. Jörg Schüttrumpf Resigns from Biotest AG Management Board Management Board Biotest AG Product Development Jörg Schüttrumpf Grifols Group
BRIEF published on 08/28/2024 at 09:05, 1 year 8 months ago Le Dr Jörg Schüttrumpf démissionne du conseil d'administration de Biotest AG Conseil D'administration Biotest AG Développement De Produits Jörg Schüttrumpf Groupe Grifols
PRESS RELEASE published on 08/28/2024 at 09:00, 1 year 8 months ago Dr. Jörg Schüttrumpf resigns from the Management Board of Biotest AG Dr. Jörg Schüttrumpf resigns as Chief Scientific Officer of Biotest AG to focus on role as Chief Scientific Innovation Officer of Grifols Group, effective August 31, 2024 Resignation Management Board Biotest AG Grifols Group Dr. Jörg Schüttrumpf
BRIEF published on 08/06/2024 at 09:05, 1 year 9 months ago Biotest Sees 35% Sales Spike in First Half of 2024 Financial Results Revenue Growth FDA Approval Biotest Yimmugo®
BRIEF published on 08/06/2024 at 09:05, 1 year 9 months ago Biotest voit ses ventes augmenter de 35 % au premier semestre 2024 Résultats Financiers Hausse Des Revenus Approbation De La FDA Biotest Yimmugo®
PRESS RELEASE published on 08/06/2024 at 09:00, 1 year 9 months ago Biotest increases sales in the first half of 2024 by 35% to Euro 372 million Biotest AG reports 35% sales increase to Euro 372 million in H1 2024. EBIT reaches Euro 78.4 million. FDA approves Yimmugo® and BNL facility. Positive revenue and earnings growth Revenue Growth FDA Approval Sales Increase Biotest AG H1 2024
BRIEF published on 07/30/2024 at 08:05, 1 year 9 months ago Biotest Reports 35% Increase in Sales for First Half of 2024 Financial Results Revenue Increase FDA Approval Sales Growth Biotest AG
BRIEF published on 07/30/2024 at 08:05, 1 year 9 months ago Biotest annonce une augmentation de 35 % de ses ventes pour le premier semestre 2024 Résultats Financiers Approbation De La FDA La Croissance Des Ventes Augmentation Des Revenus Biotest SA
Published on 05/22/2026 at 14:04, 3 hours 53 minutes ago Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Published on 05/22/2026 at 14:00, 3 hours 57 minutes ago Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Published on 05/22/2026 at 14:00, 3 hours 57 minutes ago CCL Industries Inc. Announces Renewal of Normal Course Issuer Bid and Approval of Automatic Securities Purchase Plan
Published on 05/22/2026 at 14:00, 3 hours 57 minutes ago Dateline Appoints Alvarez & Marsal to Manage Colosseum Development
Published on 05/22/2026 at 14:00, 3 hours 57 minutes ago EQ Inc. Reports First Quarter 2026 Financial Results and Annual General Meeting Results
Published on 05/22/2026 at 17:18, 39 minutes ago Chief Human Resources Officer Dr. Astrid Fontaine’s contract extended
Published on 05/22/2026 at 17:05, 52 minutes ago hep global GmbH wins financial investor FH Capital to strengthen US business
Published on 05/22/2026 at 16:44, 1 hour 12 minutes ago 2026 Annual General Meeting of Fresenius: Shareholders approve all agenda items
Published on 05/22/2026 at 16:38, 1 hour 18 minutes ago SoftwareOne shareholders approve all proposals of the Board of Directors at the 2026 Annual General Meeting
Published on 05/22/2026 at 15:30, 2 hours 26 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 05/22/2026 at 12:52, 5 hours 4 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 5 hours 4 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Published on 05/22/2026 at 08:30, 9 hours 27 minutes ago Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/22/2026 at 08:30, 9 hours 27 minutes ago Eiffage réalise quatre centrales photovoltaïques dans le cadre du programme NOOR Atlas au Maroc
